Gerrit-Anne Van Es

Showing 1-20 of 21 articles

Author Rodrigo Modolo

Coronary interventions

A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial

Modolo R, Chichareon P, Kogame N, Asano T, Chang C, de Winter R, Kaul U, Zaman A, Spitzer E, Takahashi K, Katagiri Y, Soliman O, Van Es G-A, Morel M-A, Onuma Y, Serruys P

July 19, 2019 | 10.4244/EIJ-D-18-00499

Author Pascal Vranckx

Coronary interventions

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

Vranckx P, Valgimigli M, Windecker S, Steg P, Hamm C, Jüni P, Garcia-Garcia H, Van Es G-A, Serruys P

November 20, 2016 | 10.4244/EIJY15M11_07

Author Arie-Pieter Kappetein

Coronary interventions

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Kappetein AP, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G

September 18, 2016 | 10.4244/EIJV12I7A141

Author Javier Escaned

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein AP, Taggart D, Morel M-A, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Author Vasim Farooq

The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy

Farooq V, Girasis C, Magro M, Onuma Y, Morel M-A, Heo J, Garcia-Garcia H, Kappetein AP, van den Brand M, Holmes DR, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P

December 27, 2013 | 10.4244/EIJV9I8A170

Author Vasim Farooq

The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy

Farooq V, Girasis C, Magro M, Onuma Y, Morel M-A, Heo J, Garcia-Garcia H, Kappetein AP, van den Brand M, Holmes DR, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P

March 22, 2013 | 10.4244/EIJV8I11A196

Author Arie-Pieter Kappetein

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document

Kappetein AP, Head S, Généreux P, Piazza N, Van Mieghem N, Blackstone E, Brott T, Cohen D, Cutlip D, Van Es G-A, Hahn R, Kirtane A, Krucoff M, Kodali S, Mack M, Mehran R, Rodés-Cabau J, Vranckx P, Webb J, Windecker S, Serruys P, Leon M

November 20, 2012 | 10.4244/EIJV8I7A121

Author Nicolas Van Mieghem

The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis

Van Mieghem N, Head S, van der Boon R, Piazza N, de Jaegere P, Carrel T, Kappetein AP, Lange R, Walther T, Windecker S, Van Es G-A, Serruys P

June 27, 2012 | 10.4244/EIJV8I2A40

Author Joanna Wykrzykowska

The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)

Wykrzykowska J, Serruys P, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Van Es G-A, Jüni P, Windecker S

November 30, 2011 | 10.4244/EIJV7I7A125

Author Pascal Vranckx

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

Vranckx P, Boersma E, Garg S, Valgimigli M, Van Es G-A, Goedhart D, Serruys P

November 30, 2011 | 10.4244/EIJV7I7A134

Author Joanna Wykrzykowska

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

Wykrzykowska J, Garg S, Onuma Y, de Vries T, Morel M-A, Van Es G-A, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice M, Di Mario C, van Geuns R, Jüni P, Windecker S, Serruys P

September 30, 2011 | 10.4244/EIJV7I5A97

Author Scot Garg

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

Garg S, Wykrzykowska J, Serruys P, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Tyczynski P, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

March 21, 2011

Author Giovanna Sarno

Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study

Sarno G, Garg S, Gomez-Lara J, Garcia-Garcia H, Ligthart J, Bruining N, Onuma Y, Witberg K, van Geuns R, de Boer S, Wykrzykowska J, Schultz C, Duckers H, Regar E, de Jaegere P, de Feyter P, Van Es G-A, Boersma E, van der Giessen WJ, Serruys P

March 21, 2011

Author Nicolo Piazza

Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation

Piazza N, Nuis R, Tzikas A, Otten A, Onuma Y, Garcia-Garcia H, Schultz C, van Domburg R, Van Es G-A, van Geuns R, de Jaegere P, Serruys P

September 30, 2010

Author Scot Garg

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

Garg S, Sarno G, Serruys P, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

June 30, 2010

Author Ron T. van Domburg

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

van Domburg R, Daemen J, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Van Es G-A, Wittebols K, Macours N, Stoll H, Serruys P

April 12, 2010

Author Hector Garcia-Garcia

Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting

Garcia-Garcia H, Mintz G, Lerman A, Vince G, Margolis P, Van Es G-A, Morel M, Nair A, Virmani R, Burke A, Stone G, Serruys P

June 30, 2009

Author Patrick Serruys

Assessment of the SYNTAX score in the Syntax study

Serruys P, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, van Dyck N, Mack M, Holmes DR, Feldman T, Morice M, Colombo A, Bass E, Leadley K, Dawkins K, Van Es G-A, Morel M-A, Mohr F

May 19, 2009

Author Peter P.T. de Jaegere

Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis

de Jaegere P, Piazza N, Galema T, Otten A, Soliman O, Van Dalen B, Geleijnse M, Kappetein AP, Garcia-Garcia H, Van Es G-A, Serruys P

November 20, 2008

Author Pascal Vranckx

Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water

Vranckx P, Kint P-P, Morel M-A, Van Es G-A, Serruys P, Cutlip D

August 20, 2008

1
2

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke